Table 1 Patients’ characteristics
From: Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer
Nx | % | |
|---|---|---|
Sex | ||
M | 47 | 83.9 |
F | 9 | 16.1 |
AGE Median (Range) | 69 (49 - 91) | |
Histology | ||
Urothelial | 47 | 83.9 |
Other | 3 | 5.4 |
Unknown | 6 | 10.7 |
TNM at diagnosis | ||
T | ||
Tx | 4 | 7.1 |
T2 | 2 | 3.6 |
T3 | 16 | 28.6 |
T4 | 34 | 60.7 |
N | ||
Nx | 31 | 55.4 |
N0 | 12 | 21.4 |
N1 | 10 | 17.9 |
N2 | 3 | 5.4 |
M | ||
M0/Mx | 46 | 82.1 |
M1 | 10 | 17.9 |
Grade | ||
Gr2 | 1 | 1.8 |
Gr3 | 46 | 82.1 |
Unknown | 9 | 16.1 |
PS | ||
0 | 31 | 55.4 |
1 | 17 | 30.4 |
2 | 7 | 12.5 |
3 | 1 | 1.8 |
Treatment | ||
Surgery | 18 | 32.1 |
Radio-chemotherapy | 12 | 21.4 |
Chemotherapy | 39 | 69.6 |
Radiotherapy | 1 | 1.8 |
Palliative care | 3 | 5.4 |
MMP7 (ng/mL) | ||
Mean (s.d.) | 10.6 (8.8) | |
Median (range) | 8.5 (2.8-44.2) | |